Article

Applied Clinical Trials

Linical and Accelovance Merge Under New Linical Name

Linical and Accelovance merged to create a global CRO with a significant footprint across North America, Europe and Asia-Pacific. Under this merger, they will be called Linical and have appointed a new CEO, Vita M. Lanoce.   Read the full release here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Videos
Related Content
© 2025 MJH Life Sciences

All rights reserved.